CA5

General Information


DRACP ID  DRACP05525

Peptide Name   CA5

Sequence  XACRGRGRRCGSGSRSCG

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  All cysteines form disulfide bridges with the T3-scaffold.

N-terminal Modification  FITC

C-terminal Modification  Amidation

Other Modification  X=Ahx, 6-aminohexanoic acid

Chiral  L



Physicochemical Information


Formula  C61H110N32O20S3

Absent amino acids  DEFHIKLMNPQTVWY

Common amino acids  GR

Mass  212132

Pl  11.9

Basic residues  5

Acidic residues  0

Hydrophobic residues  1

Net charge  5

Boman Index  -7445

Hydrophobicity  -97.78

Aliphatic Index  5.56

Half Life 
  /

Extinction Coefficient cystines  125

Absorbance 280nm  7.35

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24697151

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2367

DRACP is developed by Dr.Zheng's team.